Skip to Content

Harvoni 33.75 mg / 150 mg Coated granules

Licence status
Authorised: 03/07/2020
Active substances
Ledipasvir, Sofosbuvir
Dosage Form
Granules
Licence number
EU/1/14/958/004
Licence holder
Gilead Sciences Ireland UC

Licence information

ATC code
J05AP51 sofosbuvir and ledipasvir
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (see Annex I: Summary of Product Characteristics, section 4.2).
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
03/07/2020